
Please try another search
Cross Country Healthcare (NASDAQ:CCRN), Inc. CCRN is a staffing services provider that has performed brilliantly over the past year and has the potential to sustain the momentum in the near term. Consequently, if you have not taken advantage of the share-price appreciation yet, it’s time you add the stock to your portfolio.
An Outperformer: A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse over the past year. Shares of Cross Country Healthcare have returned 212.8%, significantly outperforming the 47% growth of the industry it belongs to.
Solid Rank: Cross Country Healthcare currently carries a Zacks Rank #1 (Strong Buy). Our research shows that stocks with a Zacks Rank #1 or 2 (Buy) offer attractive investment opportunities. Thus, the company is a compelling investment proposition at the moment. You can see the complete list of today’s Zacks #1 Rank stocks here.
Northward Estimate Revisions: The direction of estimate revisions serves as an important pointer when it comes to the price of a stock. Four estimates for 2021 moved north over the past 60 days versus no southward revision, reflecting analysts’ confidence in the stock. Over the same period, the Zacks Consensus Estimate for 2021 earnings has moved 73.6% north.
Positive Earnings Surprise History: Cross Country Healthcare has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in all of the trailing four quarters, delivering an average beat of 75%.
Country Healthcare is currently benefiting from the pandemic-induced increase in demand for healthcare staffing, investments in headcount and technology, and an increase in operational effectiveness.
Digital transformation and operational efficiency have been enabling the company to cater to the continuously increasing demand in specialties such as emergency room, operating room, labor, pediatrics, and delivery and medical-surgical services. The recent acquisition of Workforce Solutions Group expands Cross Country Healthcare’s go-to-market strategy and strengthens its foothold in the home care market.
Some other stocks in the broader Business Services sector that investors can consider are Avis Budget (NASDAQ:CAR) CAR, sporting a Zacks Rank #1, and Accenture (NYSE:ACN) ACN and Charles River Associates CRAI, each carrying a Zacks Rank #2 (Buy).
Avis Budget has an expected earnings growth rate of 453.5% for the current year. The company has a trailing four-quarter earnings surprise of 76.9%, on average.
Avis Budget’s shares have surged 445.3% in the past year. The company has a long-term earnings growth of 18.8%.
Accenture has an expected earnings growth rate of 19.8% for the current year. The company has a trailing four-quarter earnings surprise of 5.3%, on average.
Accenture’s shares have surged 58.4% in the past year. The company has a long-term earnings growth of 10%.
Charles River Associates has an expected earnings growth rate of 61.2% for the current year. The company has a trailing four-quarter earnings surprise of 51%, on average.
Charles River’s shares have surged 82.6% in the past year. The company has a long-term earnings growth of 15.5%.
Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?
From inception in 2012 through November, the Zacks Top 10 Stocks gained an impressive +962.5% versus the S&P 500’s +329.4%. Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.
Be First To New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Accenture PLC (ACN): Free Stock Analysis Report
Charles River Associates (CRAI): Free Stock Analysis Report
Avis Budget Group, Inc. (CAR): Free Stock Analysis Report
Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Investors are on edge about what tariff policy means for markets Coming off a strong Q4 earnings season, fresh February corporate sales figures can help assess the macro...
Broadcom stock is in a dynamic rebound phase. Markets seem optimistic ahead of the earnings release. Let's take a deep dive into what to expect from the report. Get the...
Consumers are feeling the pinch from inflation every time they go to the grocery store. Money is a zero-sum game; as disposable income and buying power erodes, consumers are...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.